Related Experiment Video
Updated: Jan 21, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes.
Venkateswaran Rajagopalan1,2, Erik P Pioro3,4
1Department of Electrical and Electronics Engineering, Birla Institute of Technology and Science, Pilani, Hyderabad, India.
Amyotrophic lateral sclerosis (ALS) patients with corticospinal tract (CST) hyperintensity on MRI represent a distinct subtype. This subtype, identified via neuroimaging, shows faster progression and may have unique disease mechanisms.
Area of Science:
- Neuroimaging
- Neurology
- Neurodegenerative Diseases
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with varied clinical presentations.
- Specific MRI findings, like T2/PD-weighted hyperintensity along the corticospinal tract (CST), are observed in some ALS patients with upper motor neuron (UMN) signs.
- These patients often exhibit younger age and accelerated disease progression.
Purpose of the Study:
- To investigate whether ALS patients with CST hyperintensity (ALS-CST+) constitute a distinct clinical subtype.
- To differentiate ALS-CST+ from other ALS subtypes, including UMN-predominant ALS without CST hyperintensity, classic ALS, and ALS with frontotemporal dementia (FTD).
Main Methods:
- Utilizing conventional MRI (cMRI) with T2-, PD-, and FLAIR-weighted sequences for initial identification of CST hyperintensity.
- Employing advanced MR techniques, including diffusion tensor imaging (DTI).
- Applying fractal dimension analysis on cMRI data.
Main Results:
- Neuroimaging analyses, including fractal dimension and DTI, revealed significant differences between the ALS-CST+ group and other ALS subtypes.
- The ALS-CST+ group is distinguishable from other ALS subtypes based on these neuroimaging findings.
Conclusions:
- ALS patients with CST hyperintensity represent a distinct clinical subtype.
- This subtype can be identified using conventional MRI techniques.
- Potential differences in disease pathogenesis may exist within the ALS-CST+ group.
More Related Videos
Related Concept Videos
Identifying Statistically Significant Differences: The F-Test
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Arteries of the Upper Limbs
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
Electric Potential and Potential Difference
When a test charge moves from the initial to the final position, the electric potential difference between those positions is defined as the ratio of the change in the potential energy to the charge on the...

